Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2011 1
2012 2
2013 2
2014 2
2015 2
2016 1
2017 2
2018 2
2019 14
2020 7
2021 10
2022 7
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability.
Massimino M, Stella S, Tirrò E, Pennisi MS, Stagno F, Vitale SR, Romano C, Tomarchio C, Parrinello NL, Manzella L, Di Raimondo F, Vigneri P. Massimino M, et al. Among authors: manzella l. Onco Targets Ther. 2023 Oct 3;16:803-816. doi: 10.2147/OTT.S413825. eCollection 2023. Onco Targets Ther. 2023. PMID: 37807980 Free PMC article.
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study.
Bucalo A, Conti G, Valentini V, Capalbo C, Bruselles A, Tartaglia M, Bonanni B, Calistri D, Coppa A, Cortesi L, Giannini G, Gismondi V, Manoukian S, Manzella L, Montagna M, Peterlongo P, Radice P, Russo A, Tibiletti MG, Turchetti D, Viel A, Zanna I, Palli D, Silvestri V, Ottini L. Bucalo A, et al. Among authors: manzella l. Eur J Cancer. 2023 Jul;188:183-191. doi: 10.1016/j.ejca.2023.04.022. Epub 2023 May 2. Eur J Cancer. 2023. PMID: 37262986 Free article.
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer.
Stella S, Vitale SR, Massimino M, Motta G, Longhitano C, Lanzafame K, Martorana F, Fazzari C, Vecchio GM, Tirrò E, Inzerilli N, Carciotto R, Manzella L, Caruso M, Vigneri P. Stella S, et al. Among authors: manzella l. Cancer Genomics Proteomics. 2022 Jul-Aug;19(4):464-476. doi: 10.21873/cgp.20333. Cancer Genomics Proteomics. 2022. PMID: 35732329 Free PMC article.
58 results